Biosynthetic production of steviol glycoside rebaudioside D4 from rebaudioside E

US11306340B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11306340-B2
Application numberUS-201916562559-A
CountryUS
Kind codeB2
Filing dateSep 6, 2019
Priority dateMar 6, 2017
Publication dateApr 19, 2022
Grant dateApr 19, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates, in some aspects, to the production of steviol glycoside rebaudioside D4 through the use of rebaudioside E. In some aspects, the invention relates to mutant CP1 enzymes, mutant HV1 enzymes as well as host cells and methods utilizing such enzymes, such as to produce rebaudioside D4.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of producing rebaudioside D4, the method comprising incubating a substrate with a recombinant polypeptide comprising an amino acid sequence having at least 90% identity to SEQ ID NO: 7 or SEQ ID NO: 9, wherein the substrate comprises Reb E, stevioside, or combinations thereof. 2. The method of claim 1 , further comprising incubating a recombinant sucrose synthase with the substrate and the recombinant polypeptide. 3. The method of claim 1 , wherein the recombinant polypeptide comprises an amino acid sequence having at least 95% identity to SEQ ID NO: 7. 4. The method of claim 3 , wherein the recombinant polypeptide comprises the amino acid sequence of SEQ ID NO: 7. 5. The method of claim 1 , wherein the recombinant polypeptide comprises an amino acid sequence having at least 95% identity to SEQ ID NO: 9. 6. The method of claim 5 , wherein the recombinant polypeptide comprises the amino acid sequence of SEQ ID NO: 9. 7. The method of claim 1 , wherein the substrate further comprises sucrose, uridine diphosphate (UDP), uridine diphosphate glucose (UDP-glucose), or combinations thereof. 8. The method of claim 1 , further comprising incubating an HV1 enzyme with the substrate and the recombinant polypeptide. 9. The method of claim 2 , wherein the sucrose synthase is selected from the group consisting of an Arabidopsis sucrose synthase 1, an Arabidopsis sucrose synthase 3 and a Vigna radiate sucrose synthase. 10. The method of claim 9 , wherein the sucrose synthase is an Arabidopsis thaliana sucrose synthase 1. 11. The method of claim 1 , wherein the Reb D4 produced is greater than 70% pure. 12. A method for synthesizing rebaudioside D4 from rebaudioside E, the method comprising: preparing a reaction mixture comprising rebaudioside E, a substrate selected from the group consisting of sucrose, uridine diphosphate (UDP) and uridine diphosphate glucose (UDP-glucose), and C1m2, and incubating the reaction mixture for a sufficient time to produce rebaudioside D4, wherein a glucose is covalently coupled to the rebaudioside E to produce rebaudioside D4. 13. The method of claim 12 further comprising adding a HV1 enzyme to the reaction mixture. 14. A method for synthesizing rebaudioside D4 from rebaudioside E, the method comprising: preparing a reaction mixture comprising rebaudioside E, a substrate selected from the group consisting of sucrose, uridine diphosphate (UDP) and uridine diphosphate glucose (UDP-glucose), and C1m3, and incubating the reaction mixture for a sufficient time to produce rebaudioside D4, wherein a glucose is covalently coupled to the rebaudioside E to produce rebaudioside D4. 15. The method of claim 14 further comprising adding a HV1 enzyme to the reaction mixture.

Assignees

Inventors

Classifications

  • Hexosyltransferases (2.4.1) · CPC title

  • A23L27/36Primary

    Terpene glycosides · CPC title

  • C12P19/56Primary

    having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin · CPC title

  • Histolysain (3.4.22.35) · CPC title

  • Sucrose synthase (2.4.1.13) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11306340B2 cover?
The present invention relates, in some aspects, to the production of steviol glycoside rebaudioside D4 through the use of rebaudioside E. In some aspects, the invention relates to mutant CP1 enzymes, mutant HV1 enzymes as well as host cells and methods utilizing such enzymes, such as to produce rebaudioside D4.
Who is the assignee on this patent?
Conagen Inc
What technology area does this patent fall under?
Primary CPC classification A23L27/36. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).